Breaking
Tuesday, July 7, 2026

News

🌏 NMPA Page 19

Latest pharmaceutical news, drug approvals, and NMPA regulatory updates

Showing 217–228 of 238 articles

Medium impact NewsApr 13, 2026

NMPA Priority Review Granted to AI Diagnostic Tool for Early Cancer Detection

National Medical Products Administration (NMPA) · Oncology · 6 min

Dr. Yuki Tanaka
Medium impact NewsApr 13, 2026

PMDA approves AI-driven platform: What You Need to Know

PMDA · Oncology · 6 min

Dr. Yuki Tanaka
High impact NewsApr 11, 2026

NMPA Data Integrity: What Pharmaceutical Manufacturers Must Know

NMPA · 4 min

Dr. Yuki Tanaka
Standard impact NewsApr 10, 2026

AI-Powered Clinical Trial Matching: Accelerating Drug Development in China

NMPA · Clinical Trials · 13 min

Dr. Yuki Tanaka
Standard impact NewsApr 10, 2026

Telemedicine in APAC: Opportunities & Challenges for Pharma Firms

NMPA · Digital Health · 10 min

Dr. Yuki Tanaka
High impact NewsApr 6, 2026

NMPA Grants Breakthrough Therapy Designation to Innovent's KRAS G12C Inhibitor

NMPA · advanced solid tumors · 6 min

Dr. Yuki Tanaka
High impact NewsApr 6, 2026

PMDA Accepts Shionogi Novel Influenza Drug with SAKIGAKE Designation

PMDA · Influenza treatment · 5 min

Dr. Yuki Tanaka
High impact NewsApr 6, 2026

Growth of Generics Market India: Impact of CDSCO Policy Changes on Pricing

CDSCO · chronic diseases · 9 min

Dr. Yuki Tanaka
High impact NewsApr 6, 2026

PMDA SAKIGAKE Designation: Accelerating Regenerative Medicine Market Access in Japan

PMDA · Regenerative Medicine · 8 min

Dr. Yuki Tanaka
High impact NewsApr 6, 2026

NMPA Priority Review Pathway: Accelerating Oncology & Rare Disease Drug Approvals

NMPA · Oncology · 8 min

Dr. Yuki Tanaka
High impact NewsApr 5, 2026

PMDA Expedited Review Melanoma: Impact on Japanese Treatment Paradigms

PMDA · oncology · 9 min

Dr. Yuki Tanaka
High impact NewsApr 5, 2026

Australian Biotech Solid Tumor CAR-T: What You Need to Know

TGA · oncology · 8 min

Dr. Yuki Tanaka